• Publications
  • Influence
Abstract 1470: Development & characterization of a new oncolytic immunotherapy platform based on herpes simplex virus type 1
A number of oncolytic viruses have shown single agent clinical activity and evidence of clinical synergy with immune checkpoint blockade. However, not all patients respond, and as yet most of theExpand